TrialDiabetes, obesity & metabolism2020

Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study.

Felix Aberer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.